Hikma Pharmaceuticals PLC (HIK) — Net Asset Quality Index
Hikma Pharmaceuticals PLC (HIK) has a Net Asset Quality Index of 45.9% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX5.55 Billion minus total liabilities of GBX3.00 Billion yields net assets of GBX2.55 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Hikma Pharmaceuticals PLC (HIK) financial obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hikma Pharmaceuticals PLC Net Asset Quality Index Over Time (2002–2024)
This chart shows how Hikma Pharmaceuticals PLC's Net Asset Quality Index has evolved across 23 annual periods from 2002 to 2024. As of June 2025, the index stands at 45.9%, representing net assets of GBX2.55 Billion against total assets of GBX5.55 Billion GBX. For live market cap and overall valuation, see Hikma Pharmaceuticals PLC stock valuation.
Annual Net Asset Quality Index for Hikma Pharmaceuticals PLC (2002–2024)
The table below presents the year-by-year Net Asset Quality Index for Hikma Pharmaceuticals PLC from 2002 to 2024, covering 23 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check HIK strategic asset allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 45.2% | GBX2.32 Billion | GBX5.13 Billion | GBX2.81 Billion | ▼ -2.0 pp |
| 2023 | 47.2% | GBX2.21 Billion | GBX4.68 Billion | GBX2.47 Billion | ▼ -0.8 pp |
| 2022 | 48.0% | GBX2.15 Billion | GBX4.47 Billion | GBX2.32 Billion | ▼ -8.4 pp |
| 2021 | 56.4% | GBX2.47 Billion | GBX4.37 Billion | GBX1.91 Billion | ▲ +4.5 pp |
| 2020 | 51.9% | GBX2.15 Billion | GBX4.13 Billion | GBX1.99 Billion | ▼ -2.2 pp |
| 2019 | 54.2% | GBX2.13 Billion | GBX3.93 Billion | GBX1.80 Billion | ▲ +5.6 pp |
| 2018 | 48.5% | GBX1.70 Billion | GBX3.50 Billion | GBX1.80 Billion | ▲ +3.4 pp |
| 2017 | 45.1% | GBX1.53 Billion | GBX3.39 Billion | GBX1.86 Billion | ▼ -10.2 pp |
| 2016 | 55.3% | GBX2.41 Billion | GBX4.36 Billion | GBX1.95 Billion | ▲ +3.2 pp |
| 2015 | 52.1% | GBX1.35 Billion | GBX2.60 Billion | GBX1.25 Billion | ▼ -2.0 pp |
| 2014 | 54.0% | GBX1.22 Billion | GBX2.25 Billion | GBX1.03 Billion | ▲ +0.4 pp |
| 2013 | 53.6% | GBX1.03 Billion | GBX1.93 Billion | GBX895.00 Million | ▲ +4.6 pp |
| 2012 | 49.0% | GBX847.85 Million | GBX1.73 Billion | GBX882.26 Million | ▼ -1.7 pp |
| 2011 | 50.7% | GBX798.63 Million | GBX1.58 Billion | GBX777.01 Million | ▼ -16.6 pp |
| 2010 | 67.2% | GBX750.30 Million | GBX1.12 Billion | GBX365.52 Million | ▲ +0.4 pp |
| 2009 | 66.8% | GBX683.26 Million | GBX1.02 Billion | GBX339.46 Million | ▲ +3.8 pp |
| 2008 | 63.0% | GBX609.00 Million | GBX966.46 Million | GBX357.46 Million | ▲ +15.5 pp |
| 2007 | 47.5% | GBX424.66 Million | GBX894.04 Million | GBX469.38 Million | ▼ -24.1 pp |
| 2006 | 71.6% | GBX349.80 Million | GBX488.36 Million | GBX138.56 Million | ▼ -0.6 pp |
| 2005 | 72.2% | GBX287.48 Million | GBX397.96 Million | GBX110.48 Million | ▲ +13.3 pp |
| 2004 | 58.9% | GBX145.18 Million | GBX246.48 Million | GBX101.31 Million | ▲ +7.6 pp |
| 2003 | 51.3% | GBX60.47 Million | GBX117.86 Million | GBX57.39 Million | ▲ +0.7 pp |
| 2002 | 50.6% | GBX48.03 Million | GBX94.86 Million | GBX46.84 Million | — |